1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Synthetic Biology Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Synthetic Biology Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems
5.2 Market Opportunities
- 5.2.1 Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry
5.3 Future Trends
- 5.3.1 Rising Number of Start-Ups
5.4 Impact of Drivers and Restraints
6. Europe Synthetic Biology Market Regional Analysis
6.1 Europe Synthetic Biology Market Overview
6.2 Europe Synthetic Biology Market Revenue 2019-2028 (US$ Million)
6.3 Europe Synthetic Biology Market Forecast Analysis
7. Europe Synthetic Biology Market Analysis – by Products
7.1 Enzymes
- 7.1.1 Overview
- 7.1.2 Enzymes: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chassis Organisms
- 7.2.1 Overview
- 7.2.2 Chassis Organisms: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oligonucleotides
- 7.3.1 Overview
- 7.3.2 Oligonucleotides: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Xeno-Nucleic Acids
- 7.4.1 Overview
- 7.4.2 Xeno-Nucleic Acids: Europe Synthetic Biology Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Synthetic Biology Market Analysis – by Technology
8.1 Measurement & Modeling
- 8.1.1 Overview
- 8.1.2 Measurement & Modeling: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cloning & Sequencing
- 8.2.1 Overview
- 8.2.2 Cloning & Sequencing: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Genome Engineering
- 8.3.1 Overview
- 8.3.2 Genome Engineering: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Gene Synthesis
- 8.4.1 Overview
- 8.4.2 Gene Synthesis: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Nanotechnology
- 8.5.1 Overview
- 8.5.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Synthetic Biology Market Analysis – by Application
9.1 Medical Applications
- 9.1.1 Overview
- 9.1.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Industrial Applications
- 9.2.1 Overview
- 9.2.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Food and Agriculture
- 9.3.1 Overview
- 9.3.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Environmental Applications
- 9.4.1 Overview
- 9.4.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Synthetic Biology Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Synthetic Biology Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Synthetic Biology Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.1.2 UK: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.1.3 UK: Europe Synthetic Biology Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.2.2 Germany: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.2.3 Germany: Europe Synthetic Biology Market Breakdown, by Application
- 10.1.1.3 France:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.3.2 France: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.3.3 France: Europe Synthetic Biology Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.4.2 Russia: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.4.3 Russia: Europe Synthetic Biology Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.5.2 Italy: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.5.3 Italy: Europe Synthetic Biology Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Products
- 10.1.1.6.2 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Technology
- 10.1.1.6.3 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Synthetic Biology Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Amyris
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Codexis
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Genscript Biotech corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Integrated DNA Technologies
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novozymes A/S
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Twist Bioscience
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Synthetic Biology Market
